Preclinical evaluation of hematopoietic toxicity of antileukemic agent, 5-AZA-2′-deoxycytidine
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 57 (3) , 329-336
- https://doi.org/10.1016/0300-483x(89)90120-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Molecular, cellular and animal pharmacology of 5-AZA-2′-deoxycytidinePharmacology & Therapeutics, 1985
- Clinical trial on 5-AZA-2′-deoxycytidine in patients with acute leukemiaPharmacology & Therapeutics, 1985
- Cell cycle effects and cellular pharmacology of 5-AZA-2?-deoxycytidineCancer Chemotherapy and Pharmacology, 1984
- Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemiaLeukemia Research, 1984
- Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemiaLeukemia Research, 1981
- DNA Methylation and Gene FunctionScience, 1980
- Cellular differentiation, cytidine analogs and DNA methylationPublished by Elsevier ,1980
- EFFECT OF INTRAVENOUS-INFUSION OF 5-AZA-2'-DEOXYCYTIDINE ON SURVIVAL TIME OF MICE WITH L1210 LEUKEMIA1978